Santarus News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.01.17	ABI Research Unveils its NRF 2018 Market Predictions, One Year Early (PR Newswire)
23.12.13	Santarus Begins Phase IIa Study With SAN-300 In Rheumatoid Arthritis Patients (RTTNews)
03.12.13	Salix Pharma Commences Cash Tender Offer For Santarus Stock - Quick Facts (RTTNews)
08.11.13	Santarus, Pharming Announce New Data From RUCONEST's Repeat Treatment Study (RTTNews)
08.11.13	Salix Pharma To Buy Santarus In $2.6 Billion Deal; Q4 Adj Profit Tops View (RTTNews)
07.11.13	Salix Pharmaceuticals To Buy Santarus For $32/Shr - Quick Facts (RTTNews)
11.10.13	Technical Study: Isis Pharma Inc., Santarus Inc., Community Health Systems Inc., and Quest Diagnostics Inc. (PR Newswire)
04.10.13	Santarus To Present Phase III Data For Rifamycin SV MMX In Travelers' Diarrhea (RTTNews)
02.10.13	Critical Alerts For HSBC, Cree, Santarus, MGM Mirage, and Alexion Pharmaceuticals Released By InvestorsObserver (PR Newswire)
12.09.13	Pre-Market Review: Isis Pharmaceuticals Inc., Community Health Systems Inc., Quest Diagnostics Inc., and Santarus Inc. (PR Newswire)
21.08.13	Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA (PR Newswire)
09.08.13	Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte (PR Newswire)
08.08.13	Critical Alerts For SunPower, Boston Properties, T-Mobile, ImmunoGen, and Santarus Released By InvestorsObserver (PR Newswire)
07.08.13	Pre-Market Analysis: Community Health Systems, Isis Pharmaceuticals, Quest Diagnostics, and Santarus Inc. (PR Newswire)
07.08.13	Santarus Q2 Profit, Revenue Surges; Stock Rises - Update (RTTNews)
07.08.13	AVNR Nears PRIME Time, CRTX Turns The Corner, NSPH Falls Big, Busy Time For PBYI (RTTNews)
06.08.13	Santarus Q2 Profit Surges - Quick Facts (RTTNews)
05.08.13	Accretive Collaborations, Strengthened Management, and Earnings Release Schedules - Research Report on Seattle Genetics, Santarus, BioCryst, NPS, and PDL BioPharma (PR Newswire)
24.07.13	Marketing Applications, Product Launches, Commencement of Studies, Collaborations, and Release of Funding - Research Report on Biogen Idec, Illumina, Santarus, Celsion, and BioCryst (PR Newswire)
03.03.10	Santarus Reports Fourth Quarter and Full Year 2009 Financial Results (Businesswire)
22.12.09	Santarus Receives Previously Announced $20 Million Milestone for FDA Approval of ZEGERID OTC (Businesswire)
12.10.09	Santarus and Norgine Enter License for ZEGERID Immediate-Release Omeprazole Products in Europe (Businesswire)
06.05.09	Santarus Reports First Quarter 2009 Financial Results (Businesswire)
03.11.08	Santarus Reports Third Quarter 2008 Financial Results (Businesswire)
28.05.08	Santarus Announces Development Program for New ZEGERID Prescription Product (Businesswire)
03.03.08	Santarus Reports Fourth Quarter and Full Year 2007 Financial Results (Businesswire)
28.06.07	Santarus and Victory Pharma Announce Co-Promotion Agreement for NAPRELAN Prescription Products (Businesswire)
16.05.05	Santarus to Present at UBS Global Pharmaceuticals Conference (Businesswire)
12.05.05	Santarus Reports First Quarter 2005 Financial Results; Conference call (Businesswire)
22.02.05	Santarus Launches ZEGERID Powder for Oral Suspension 40 mg (Businesswire)
16.02.05	Santarus Appoints Dr. Michael G. Carter to Board of Directors (Businesswire)
15.02.05	Santarus to Present at Roth Capital Partners 17th Annual Growth Stock (Businesswire)
09.02.05	Santarus Announces Positive Results from Pivotal PK/PD Clinical Trials (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Santarus Inc Cash Settlement At USD 32.00 A Sh

Aktien Top/Flop

Meistgelesene Nachrichten